Abstract:Background: Baicalin is the main bioactive constitute of the dried roots of Scutellaria baicalensis and possesses various biological activities. However, the poor water solubility and low oral bioavailability limit its efficacy. Objective: The present study was conducted to enhance the dissolution and oral bioavailability of baicalin (BA) through a novel mesoporous carbon nanopowder (MCN) drug carrier. Materials and methods: Solid dispersions (SDs) of BA with MCN were prepared using a solvent evaporation method. The physical state of the formulations was investigated using SEM, differential scanning calorimetry (DSC) and powder X-ray diffraction (XRD). The pharmaceutical performance of pure BA, physical mixture (PM) and SDs was evaluated by performing an in-vitro dissolution test. The pharmacokinetic studies were conducted in SD rats and the analysis of the biological samples was performed on an Acquity UPLC-MS system. The intestinal and renal toxicity test of MCN was also evaluated. Results: The drug release profile indicated that the BA dissolution rate from SDs with a BA/MCN ratio of 1:6 greatly increased in comparison with that of the pure crystalline drug. Furthermore, a pharmacokinetic analysis in rats showed that the BA area under the concentration-time curve for SDs of MCN/BA was 1.83 times larger than that of pure BA. In comparison with the pure drug, the MCN-BA system significantly shortened the time to Tmax and generated higher Cmax. There was no intestinal and renal toxicity of MCN. Conclusion: These results indicated that the oral bioavailability of BA was remarkably improved by the MCN carrier. Additionally, intestinal toxicity test showed that MCN produced no toxicity in the gastrointestinal tract. Our results show that MCN-based SDs could be used to enhance the bioavailability of drugs with poor water solubility. Summary: The drug release profile indicated that the BA dissolution rate from SDs with a BA/MCN ratio of 1:6 greatly increased in comparison with that of the pure crystalline drug.Furthermore, a pharmacokinetic analysis in rats showed that the BA area under the concentration-time curve for SDs of MCN/BA was 1.83 times larger than that of pure BA.In comparison with the pure drug, the MCN-BA system significantly shortened the time to Tmax and generated higher CmaxAbbreviations used: BA: baicalin, MCN: mesoporous carbon nanopowder, SDs: solid dispersions, SEM: scanning electron microscopy, DSC: differential scanning calorimetry, XRD: powder X-ray diffraction, HPLC: high-performance liquid chromatography, PM: physical mixture, S.D.: standard deviation, ANOVA: analysis of variance, RSD: relative standard deviation, ESI: electrospray ionization, IS: internal standard, MRM: multiple reaction monitoring.

Supramolecular interaction between berberine hydrochloride and baicalin in aqueous solution: Reaction kinetics, spectral analysis and dynamic simulation

Compound–compound interaction analysis of baicalin and berberine derivatives in aqueous solution

Characterization of Transformation Pattern of Baicalin Using UV Spectrometric Analysis and Multivariate Curve Resolution

Study on the precipitation reaction between baicalin and berberine by HPLC

Baicalin-berberine complex nanocrystals orally promote the co-absorption of two components

Chemical Characterization of the Precipitate Found in and Its Effect on Drug Release of the Scutellaria baicalensis-Coptis chinensis Extract

Comprehensive analysis of Huanglian Jiedu decoction: Revealing the presence of a self-assembled phytochemical complex in its naturally-occurring precipitate

Probing berberine syringate-bovine serum albumin interactions by multi-spectroscopic, conductimetric, volumetric and molecular docking methods

[Composition and morphology of Scutellariae Radix-Coptidis Rhizoma decoction co-precipitate and effect on in vivo behavior of decocting liquid]

Application of Pharmacodynamics-Based Optimization to the Extraction of Bioactive Compounds from Chansu

Complexation of Baicalin with Ferrous (II) and Its Characterization

Characterization and Bioavailability Study of Baicalin-mesoporous Carbon Nanopowder Solid Dispersion

Investigation on Intermolecular Interaction Between Berberine and Β-Cyclodextrin by 2D UV–Vis Asynchronous Spectra

Preparation, Characterization and in Vivo Evaluation of Formulation of Baicalein with Hydroxypropyl-Beta-Cyclodextrin

Interaction of baicalin with berberine for glucose uptake in 3T3-L1 adipocytes and HepG2 hepatocytes

Characterization and Evaluation in Vivo of Baicalin-Nanocrystals Prepared by an Ultrasonic-Homogenization-fluid Bed Drying Method

Pharmacokinetic studies of novel berberine derivatives with ultra-performance liquid chromatography-tandem mass spectrometry

Theoretical investigation of the conformational space of baicalin

Preparation, pharmacokinetics and biodistribution of baicalin-loaded liposomes

Supramolecular interaction of ethylenediamine linked beta-cyclodextrin dimer and berberine hydrochloride by spectrofluorimetry and its analytical application

Solubility and thermodynamic properties of baicalein in water and ethanol mixtures from 283.15 to 328.15 K